These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1310779)

  • 1. A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance.
    Hwang CB; Ruffner KL; Coen DM
    J Virol; 1992 Mar; 66(3):1774-6. PubMed ID: 1310779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro mutagenesis of the herpes simplex virus type 1 DNA polymerase gene results in altered drug sensitivity of the enzyme.
    Matthews JT; Carroll RD; Stevens JT; Haffey ML
    J Virol; 1989 Nov; 63(11):4913-8. PubMed ID: 2552170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
    Coen DM; Fleming HE; Leslie LK; Retondo MJ
    J Virol; 1985 Feb; 53(2):477-88. PubMed ID: 2982032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aphidicolin resistance in herpes simplex virus type I reveals features of the DNA polymerase dNTP binding site.
    Hall JD; Wang YS; Pierpont J; Berlin MS; Rundlett SE; Woodward S
    Nucleic Acids Res; 1989 Nov; 17(22):9231-44. PubMed ID: 2555788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities.
    Larder BA; Darby G
    Virology; 1985 Oct; 146(2):262-71. PubMed ID: 2996220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
    Schmit I; Boivin G
    J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of a herpes simplex virus clinical isolate exhibiting resistance to acyclovir and foscarnet.
    Pelosi E; Hicks KA; Sacks SL; Coen DM
    Adv Exp Med Biol; 1992; 312():151-8. PubMed ID: 1325102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical mapping of drug resistance mutations defines an active center of the herpes simplex virus DNA polymerase enzyme.
    Knopf KW; Kaufman ER; Crumpacker C
    J Virol; 1981 Sep; 39(3):746-57. PubMed ID: 6270349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities.
    Furman PA; Coen DM; St Clair MH; Schaffer PA
    J Virol; 1981 Dec; 40(3):936-41. PubMed ID: 6275127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-base change within the DNA polymerase locus of herpes simplex virus type 2 can confer resistance to aphidicolin.
    Tsurumi T; Maeno K; Nishiyama Y
    J Virol; 1987 Feb; 61(2):388-94. PubMed ID: 3027369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The herpes simplex virus type 1 DNA polymerase gene: site of phosphonoacetic acid resistance mutation in strain Angelotti is highly conserved.
    Knopf CW
    J Gen Virol; 1987 May; 68 ( Pt 5)():1429-33. PubMed ID: 3033142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic mechanisms of resistance to acyclovir in herpes simplex virus.
    Crumpacker CS; Schnipper LE; Chartrand P; Knopf KW
    Am J Med; 1982 Jul; 73(1A):361-8. PubMed ID: 6285723
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1.
    Coen DM; Schaffer PA; Furman PA; Keller PM; St Clair MH
    Am J Med; 1982 Jul; 73(1A):351-60. PubMed ID: 6285722
    [No Abstract]   [Full Text] [Related]  

  • 14. Fine mapping and molecular cloning of mutations in the herpes simplex virus DNA polymerase locus.
    Coen DM; Aschman DP; Gelep PT; Retondo MJ; Weller SK; Schaffer PA
    J Virol; 1984 Jan; 49(1):236-47. PubMed ID: 6317891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir.
    Collins P; Larder BA; Oliver NM; Kemp S; Smith IW; Darby G
    J Gen Virol; 1989 Feb; 70 ( Pt 2)():375-82. PubMed ID: 2543743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversion of mutations in the thymidine kinase gene in herpes simplex viruses resistant to phosphonoacetate.
    Campione-Piccardo J; Rawls WE
    Can J Microbiol; 1984 May; 30(5):560-4. PubMed ID: 6331620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the herpes simplex virus DNA polymerase gene can confer resistance to 9-beta-D-arabinofuranosyladenine.
    Coen DM; Furman PA; Gelep PT; Schaffer PA
    J Virol; 1982 Mar; 41(3):909-18. PubMed ID: 6284981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the DNA polymerases induced by a group of herpes simplex virus type I variants selected for growth in the presence of phosphonoformic acid.
    Derse D; Bastow KF; Cheng Y
    J Biol Chem; 1982 Sep; 257(17):10251-60. PubMed ID: 6286645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of penciclovir against clinical isolates of acyclovir-resistant and foscarnet-resistant herpes simplex virus.
    Safrin S; Phan L
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2241-3. PubMed ID: 8257152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of herpes simplex virus to adenine arabinoside and E-5-(2-bromovinyl)-2'-deoxyuridine: a physical analysis.
    Crumpacker CS; Schnipper LE; Kowalsky PN; Sherman DM
    J Infect Dis; 1982 Aug; 146(2):167-72. PubMed ID: 6286786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.